tiprankstipranks
Apellis Pharmaceuticals Reports Strong Growth and Leadership Changes
PremiumCompany AnnouncementsApellis Pharmaceuticals Reports Strong Growth and Leadership Changes
1M ago
Apellis reports FY24 preliminary U.S. product revenues $709M
Premium
The Fly
Apellis reports FY24 preliminary U.S. product revenues $709M
1M ago
Apellis appoints Keli Walbert to board of directors
Premium
The Fly
Apellis appoints Keli Walbert to board of directors
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
Ulta Beauty downgraded, Palo Alto upgraded: Wall Street’s top analyst calls
Premium
The Fly
Ulta Beauty downgraded, Palo Alto upgraded: Wall Street’s top analyst calls
3M ago
Apellis initiated with an Equal Weight at Morgan Stanley
Premium
The Fly
Apellis initiated with an Equal Weight at Morgan Stanley
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
Apellis price target lowered to $45 from $74 at UBS
Premium
The Fly
Apellis price target lowered to $45 from $74 at UBS
4M ago
Apellis price target lowered to $55 from $92 at Baird
Premium
The Fly
Apellis price target lowered to $55 from $92 at Baird
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100